[go: up one dir, main page]

DK40885D0 - Monoklonalt antistof, fremgangsmaade og celle til fremstilling deraf,fremgangsmaade til fremstilling af cellen og farmaceutisk praeparat indeholdende det monoklonale antistof - Google Patents

Monoklonalt antistof, fremgangsmaade og celle til fremstilling deraf,fremgangsmaade til fremstilling af cellen og farmaceutisk praeparat indeholdende det monoklonale antistof

Info

Publication number
DK40885D0
DK40885D0 DK40885A DK40885A DK40885D0 DK 40885 D0 DK40885 D0 DK 40885D0 DK 40885 A DK40885 A DK 40885A DK 40885 A DK40885 A DK 40885A DK 40885 D0 DK40885 D0 DK 40885D0
Authority
DK
Denmark
Prior art keywords
procedure
monoclonal antibody
cells
preparing
monoclonal antibodies
Prior art date
Application number
DK40885A
Other languages
English (en)
Other versions
DK171896B1 (da
DK40885A (da
Inventor
Jr Michael G Hanna
Martin V Haspel
Jr Herbert C Hoover
Original Assignee
Litton Bionetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24300700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK40885(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Litton Bionetics Inc filed Critical Litton Bionetics Inc
Publication of DK40885D0 publication Critical patent/DK40885D0/da
Publication of DK40885A publication Critical patent/DK40885A/da
Application granted granted Critical
Publication of DK171896B1 publication Critical patent/DK171896B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK040885A 1984-01-31 1985-01-30 Autolog vaccine, anvendelse af celler til fremstilling af en autolog vaccine, metode til fremstilling af en autolog vaccine, fremgangsmåde til fremstilling af et hybridom og en celle, fremgangsmåde til fremstilling af humane monoklonale antistoffer og ved disse fremgangsmåder opnåede produkter. DK171896B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57553384A 1984-01-31 1984-01-31
US57553384 1984-01-31

Publications (3)

Publication Number Publication Date
DK40885D0 true DK40885D0 (da) 1985-01-30
DK40885A DK40885A (da) 1985-10-25
DK171896B1 DK171896B1 (da) 1997-08-04

Family

ID=24300700

Family Applications (1)

Application Number Title Priority Date Filing Date
DK040885A DK171896B1 (da) 1984-01-31 1985-01-30 Autolog vaccine, anvendelse af celler til fremstilling af en autolog vaccine, metode til fremstilling af en autolog vaccine, fremgangsmåde til fremstilling af et hybridom og en celle, fremgangsmåde til fremstilling af humane monoklonale antistoffer og ved disse fremgangsmåder opnåede produkter.

Country Status (15)

Country Link
EP (1) EP0151030B1 (da)
JP (2) JPH0759518B2 (da)
AT (1) ATE71410T1 (da)
AU (2) AU589351B2 (da)
CA (1) CA1340781C (da)
DE (1) DE3585093D1 (da)
DK (1) DK171896B1 (da)
ES (1) ES8802621A1 (da)
GR (1) GR850179B (da)
HU (1) HU209519B (da)
IE (1) IE58859B1 (da)
IL (1) IL74156A (da)
NZ (1) NZ210867A (da)
PT (1) PT79894B (da)
ZA (1) ZA85689B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3319751A1 (de) * 1983-05-31 1984-12-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung von gegen tumorantigene gerichteten monoklonalen antikoerpern und diese enthaltende arzneimittel
US6294172B1 (en) 1983-08-12 2001-09-25 Dade Behring Marburg Gmbh Monoclonal antibodies with specificity for membrane-associated antigens
DE3629640A1 (de) * 1986-08-30 1988-03-03 Behringwerke Ag Verwendung monoklonaler antikoerper zur therapie von tumoren
US5011684A (en) * 1985-09-05 1991-04-30 Beth Israel Hospital Association Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance
JPS6283898A (ja) * 1985-10-09 1987-04-17 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺腺癌特異的単クロ−ン性抗体
US5552291A (en) * 1985-10-09 1996-09-03 Kyowa, Hakko Kogyo Co., Ltd. Anti-human pulmonary adenocarcinoma specific monoclonal antibody
EP0222360A3 (en) * 1985-11-12 1989-03-15 Biotherapeutics Inc. A method of producing a patient-specific cytotoxic reagent and composition
JPS62207298A (ja) * 1986-03-06 1987-09-11 Kyowa Hakko Kogyo Co Ltd 抗ヒト胃癌単クロ−ン性抗体
JPH06100843B2 (ja) * 1986-06-23 1994-12-12 キヤノン株式会社 絶縁性磁性乾式現像剤
EP0265156A3 (en) * 1986-10-14 1990-08-29 Bunge (Australia) Proprietary Limited Monoclonal antibodies
DK169987D0 (da) * 1987-04-03 1987-04-03 Jens Christian Jensenius Human tumor-associated antigen, ca-ou1
DE3855280T2 (de) * 1987-07-02 1996-09-19 Akzo Nv Von mca 16-88 erkanntes antigen
US5215913A (en) 1987-11-30 1993-06-01 Roger Williams General Hospital IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use
DE3909799A1 (de) 1989-03-24 1990-09-27 Behringwerke Ag Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
DK0429624T3 (da) * 1989-06-19 1994-05-30 Akzo Nobel Nv Radioimmunterapi under anvendelse af alfa-partikelemission
ES2090331T3 (es) * 1990-04-12 1996-10-16 Akzo Nobel Nv Ctaa 28a32, antigeno reconocido por mca 28a32.
FI925804L (fi) * 1990-07-03 1992-12-21 Akzo Nv Immunologiskt reaktiv foerening
US5281710A (en) * 1990-08-01 1994-01-25 The Scripps Research Institute Dynemicin analogs: synthesis, methods of preparation and use
ATE183546T1 (de) * 1991-05-16 1999-09-15 Perimmune Holdings Inc Tumorspezifischer monoklonaler antikörper 81av78
IL103758A (en) * 1991-12-13 1998-07-15 Akzo Nv Tumor specific monoclonal antibodies
JPH06113831A (ja) * 1992-04-08 1994-04-26 Dev Center For Biotechnol ハイブリドーマおよびその抗体
EP0650735A3 (en) * 1993-07-09 1999-04-14 Akzo Nobel N.V. Kit and method for pretargeting
EP1567175B1 (en) 2002-02-22 2009-01-21 Intracel Recources LLC Sterile immunogenic non-tumorigenic tumor cell compositions and methods
US7176022B2 (en) 2002-12-20 2007-02-13 Cell Genesys, Inc. Directly injectable formulations which provide enhanced cryoprotection of cell products
CN106133521A (zh) * 2013-10-02 2016-11-16 苏瑞科技有限公司 用于治疗异质肿瘤的病患特异性的免疫疗法
EP3409297A1 (en) 2017-05-30 2018-12-05 AlfaRim Medial Holding B.V. The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy
WO2019057598A1 (en) 2017-09-20 2019-03-28 Alfarim Medical Holding B.V. OPTIMAL 225ACTINIUM - 213BISMUTH GENERATOR FOR ALPHA PARTICLE RADIO IMMUNOTHERAPY

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4322879A (en) * 1978-01-11 1979-07-19 Massachusetts General Hospital, The Producing antibodies
DE3211356A1 (de) * 1982-03-27 1983-09-29 Behringwerke Ag, 3550 Marburg Zell-hybrid, verfahren zu seiner herstellung sowie seine verwendung
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58201994A (ja) * 1982-05-21 1983-11-25 Hideaki Hagiwara 抗原特異的ヒト免疫グロブリンの生産方法
US4613576A (en) * 1983-03-09 1986-09-23 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cancer cells

Also Published As

Publication number Publication date
JPS60260597A (ja) 1985-12-23
AU635511B2 (en) 1993-03-25
DK171896B1 (da) 1997-08-04
GR850179B (da) 1985-05-23
PT79894A (en) 1985-02-01
AU3799285A (en) 1985-08-08
HUT36859A (en) 1985-10-28
PT79894B (en) 1986-10-23
EP0151030A2 (en) 1985-08-07
EP0151030A3 (en) 1987-11-25
IE58859B1 (en) 1993-11-17
AU4736789A (en) 1990-05-03
IE850192L (en) 1985-07-31
JP2516731B2 (ja) 1996-07-24
IL74156A0 (en) 1985-04-30
ZA85689B (en) 1986-04-30
CA1340781C (en) 1999-10-12
NZ210867A (en) 1989-01-06
IL74156A (en) 1990-08-31
DK40885A (da) 1985-10-25
AU589351B2 (en) 1989-10-12
JPH0759518B2 (ja) 1995-06-28
ES539987A0 (es) 1988-09-16
DE3585093D1 (de) 1992-02-20
HU209519B (en) 1994-06-28
ES8802621A1 (es) 1988-09-16
EP0151030B1 (en) 1992-01-08
ATE71410T1 (de) 1992-01-15
JPH06315395A (ja) 1994-11-15

Similar Documents

Publication Publication Date Title
DK40885A (da) Monoklonalt antistof, fremgangsmaade og celle til fremstilling deraf,fremgangsmaade til fremstilling af cellen og farmaceutisk praeparat indeholdende det monoklonale antistof
ATE101202T1 (de) Antikoerper.
DK164510C (da) Humant hybridom, humant monoklonalt antistof opnaaet derfra, anvendelse af et saadant antistof og fremgangsmaade til fremstilling af et saadant antistof
DK478886D0 (da) Monoklonalt murinantistof egnet til genkendelse af brysttumorer og immunogenkendelsesmiddel omfattende samme samt fremgangsmaade til genkendelse af samme
ES8705975A1 (es) Un metodo de deteccion o localizacion de celulas de carcinoma humano.
EP0232871A3 (en) Human monoclonal antibody, hybridoma producing the same and its use
ATE71225T1 (de) Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten.
IL86958A0 (en) Human monoclonal antibody igm 16-88,cell lines producing it and antigen recognized thereby
EP0537168A4 (en) Ctaa 28a32, the antigen recognized by mca 28a32
NO924803L (no) Tumor-relatert monoklonalt antistoff 88bv59
EP0584267A4 (en) TUMOR-SPECIFIC MONOCLONAL ANTIBODY 81AV78.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed